Evidence map›Paper›PMID 31848320›Full record

ArticleScience signaling2019

Genetic diversity affects the nanoscale membrane organization and signaling of natural killer cell receptors.

Philippa R Kennedy, Charlotte Barthen, David J Williamson, William T E Pitkeathly, Khodor S Hazime, Joshua Cumming, Kevin B Stacey, Hugo G Hilton, Mary Carrington, Peter Parham and 1 more

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Nanoscale restructuring of the immune synapse with an engager enhances NK cell function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Spatial localization of CD16a at the human NK cell ADCC lytic synapse.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Licensing Natural Killers for Antiviral Immunity.Pathogens (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Philippa R KennedyManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.ORCID 0000-0003-0239-5440
Charlotte BarthenManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
David J WilliamsonManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.ORCID 0000-0002-6222-6297
William T E PitkeathlyManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
Khodor S HazimeManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.ORCID 0000-0001-5125-2011
Joshua CummingManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
Kevin B StaceyManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.ORCID 0000-0001-9500-7165
Hugo G HiltonDepartment of Structural Biology, Stanford University School of Medicine, D159, Sherman Fairchild Science Building, 299 Campus Drive West, Stanford, CA 94305, USA.ORCID 0000-0003-1488-7194
Mary CarringtonBasic Science Program, Frederick National Laboratory for Cancer Research, Building 560, Room 21-89, Frederick, MD 21702, USA.ORCID 0000-0002-2692-2180
Peter ParhamDepartment of Structural Biology, Stanford University School of Medicine, D159, Sherman Fairchild Science Building, 299 Campus Drive West, Stanford, CA 94305, USA.
Daniel M DavisManchester Collaborative Centre for Inflammation Research, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK. daniel.davis@manchester.ac.uk.ORCID 0000-0002-9182-291X
University of Manchester · GBFairchild Semiconductor (United States) · USRagon Institute of MGH, MIT and Harvard · US

Funding

Biotechnology and Biological Sciences Research Council BB/I013407/1CCR NIH HHS HHSN261200800001CMedical Research Council G1001044NCI NIH HHS HHSN261200800001EWellcome Trust 110091
6 · The paper itself

Abstract

Genetic diversity in human natural killer (NK) cell receptors is linked to resistance and susceptibility to many diseases. Here, we tested the effect of this diversity on the nanoscale organization of killer cell immunoglobulin-like receptors (KIRs). Using superresolution microscopy, we found that inhibitory KIRs encoded by different genes and alleles were organized differently at the surface of primary human NK cells. KIRs that were found at low abundance assembled into smaller clusters than those formed by KIRs that were more highly abundant, and at low abundance, there was a greater proportion of KIRs in clusters. Upon receptor triggering, a structured interface called the immune synapse assembles, which facilitates signal integration and controls NK cell responses. Here, triggering of low-abundance receptors resulted in less phosphorylation of the downstream phosphatase SHP-1 but more phosphorylation of the adaptor protein Crk than did triggering of high-abundance receptors. In cells with greater KIR abundance, SHP-1 dephosphorylated Crk, which potentiated NK cell spreading during activation. Thus, genetic variation modulates both the abundance and nanoscale organization of inhibitory KIRs. That is, as well as the number of receptors at the cell surface varying with genotype, the way in which these receptors are organized in the membrane also varies. Essentially, a change in the average surface abundance of a protein at the cell surface is a coarse descriptor entwined with changes in local nanoscale clustering. Together, our data indicate that genetic diversity in inhibitory KIRs affects membrane-proximal signaling and, unexpectedly, the formation of activating immune synapses.

Indexed as

Genetic VariationImmunological SynapsesReceptors, KIRSignal TransductionCell Line, TumorHumansKiller Cells, NaturalProtein Tyrosine Phosphatase, Non-Receptor Type 6Proto-Oncogene Proteins c-crkCRK protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 6Proto-Oncogene Proteins c-crkReceptors, KIR

Identifiers

PMID31848320
PMCPMC6944503
OpenAlexW2992999886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.